IL-12 binds to the heterodimeric receptor IL12RB1/IL12RB2 and activates downstream STAT4, initiating Th1 immune responses and anti-tumor immunity. Parental 293T cells lack endogenous expression of these receptor subunits and STAT4, making them unsuitable for direct IL-12 pathway activity detection.
We generated the engineered cell line 293T-STAT4-Luc2-IL12RB1-IL12RB2 with stable overexpression of IL12RB1, IL12RB2 and STAT4, alongside a Luc2 luciferase reporter responsive to STAT4 activation. This cell model allows quantitative luminescence measurement of IL-12 signaling intensity, suitable for rapid screening of IL-12 modulators and functional validation of the IL-12/STAT4 axis in tumor immunology research.